Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants. 2010

Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. acton@uab.edu <acton@uab.edu>

We sought to determine if TNF promoter variants could explain iron phenotype heterogeneity in adults with previous HFE genotyping. HEIRS Study participants genotyped for C282Y and H63D were designated as high transferrin saturation (TS) and/or serum ferritin (SF) (high TS/SF), low TS/SF, or controls. We grouped 191 C282Y homozygotes as high TS/SF, low TS/SF, or controls, and 594 other participants by race/ethnicity as high TS/SF or controls. Using denaturing high-performance liquid chromatography (DHPLC), we screened the TNF promoter region in each participant. We performed multiple regression analyses in C282Y homozygotes using age, sex, HEIRS Study Field Center, and positivity for TNF -308G-->A and -238G-->A to determine if these attributes predicted ln TS or ln SF. DHPLC analyses were successful in 99.3% of 791 participants and detected 9 different variants; TNF -308G-->A and -238G-->A were the most prevalent. Most subjects positive for variants were heterozygous. The phenotype frequencies of each variant did not differ significantly (p<0.05) across subgroups of C282Y homozygotes, or across white, black, Hispanic, and Asian non-C282Y homozygotes subgrouped as high TS/SF phenotypes and controls. TNF -308G-->A positivity was a significant predictor of initial screening ln TS but not ln SF; TNF -238G-->A predicted neither ln TS nor ln SF. We conclude that TNF promoter variants have little, if any, effect on initial screening SF values in adults with or without C282Y homozygosity. We cannot exclude a possible association of homozygosity for TNF promoter variants on TS and SF values.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D005260 Female Females
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic

Related Publications

Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
January 2009, Hematology. American Society of Hematology. Education Program,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
December 2008, Genetic testing,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
October 2007, Genetics in medicine : official journal of the American College of Medical Genetics,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
January 2017, Annals of hepatology,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
June 2001, Blood,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
November 2006, Genetics in medicine : official journal of the American College of Medical Genetics,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
September 1981, Der Internist,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
July 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
August 2006, Clinical chemistry,
Ronald T Acton, and James C Barton, and Catherine Leiendecker-Foster, and Christopher Zaun, and Christine E McLaren, and John H Eckfeldt
November 2007, Genetics in medicine : official journal of the American College of Medical Genetics,
Copied contents to your clipboard!